This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC, and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC, is accredited by the ACCME to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 21.75 contact hours (2.175 CEUs) under the ACPE universal activity numbers:
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 24.25 Contact Hours.
Acknowledgement of Commercial Support
This activity is supported by educational grants from AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; and Seattle Genetics, Inc.; Jazz Pharmaceuticals, Inc.
38th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
Wednesday, November 4, 2020 – Friday, November 6, 2020
38th Annual Chemotherapy Foundation Symposium Overview
Exciting new breakthroughs and rapid changes continue to occur in the management of solid and hematologic malignancies. Just this past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to enter the field. The application of optimized testing approaches, locoregional and systemic therapies, including the use of chemotherapies, targeted therapies, immunotherapies, alone and in combination, along with multimodal strategies, continue to drive improved outcomes across multiple lines of care. Critical knowledge, competence, and performance gaps among practitioners must be addressed to ensure that these approaches are effectively and safely integrated into professional practice.
Each year, the Chemotherapy Foundation Symposium® (CFS®), brings together more than 2000 healthcare professionals for 3 days, with the aim of promoting the delivery of evidence-based, state-of-the-art cancer care for both routine and the most challenging clinical scenarios. At the 38th Annual CFS®, our internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering an unparalleled opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize care and outcomes for your patients with cancer.Benefits of Attending.
- Incorporate the latest clinical data and evidence-based strategies into your practice
- Learn experts’ viewpoints on areas of clinical uncertainty
- Network with the top minds in oncology
- 100 Experts. 25 Tumor Types. 3 Days. 1 Meeting. Something for everyone!
Acknowledgement of Commercial Support
This activity is supported by educational grants from AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Novartis Pharmaceuticals Corporation; Seattle Genetics, Inc.;
and Jazz Pharmaceuticals, Inc.
This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists involved in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend.
38th Annual Chemotherapy Foundation Symposium Co-Chairs
Associate Professor, Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Chief, Division of Hematology and Medical Oncology
Deputy Director, Tisch Cancer Institute
Professor of Medicine and Urology
Ezra M. Greenspan, MD, Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
New York, NY
Associate Attending Physician
Vice Chair, Oncology (Manhattan) Dept of Medicine
Clinical Director, Breast Medicine Service
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, NY
38th Annual Chemotherapy Foundation Symposium Registration
Physicians' Education Resource
2 Clarke Drive, Suite 110
Cranbury, NJ 08512
|Nurses, PAs, Other Health Care Professionals||$179|
Daily rates are now available, please call (877) 303-0104 for pricing.
*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email email@example.com, or call (888) 949-0045 or (609) 378-3701.
A cancellation fee of 25% will be assessed on refunds requested prior to August 4, 2020, and a 50% fee on refunds requested on August 4, 2020 through September 4, 2020. No refunds will be made after September 4, 2020. There is no charge for substitution. Substitutions can be applied only to the same conference, and just 2 substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
Physicians’ Education Resource®, LLC (PER®), fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.
PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.
By attending a PER® conference, meeting, or related activity (“Events”), all participants, attendees, exhibitors, sponsors, and guests (“you”) create an agreement between you and PER® regarding the use and distribution of your image, including, but not limited to, your name, voice, and likeness (“Image”). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.
You must be logged in to PER to register for this meeting
Or Register for PER now